These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11782039)

  • 1. A comparison of methods for adaptive sample size adjustment.
    Friede T; Kieser M
    Stat Med; 2001 Dec; 20(24):3861-73. PubMed ID: 11782039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.
    Shih WJ; Gould AL
    Stat Med; 1995 Oct; 14(20):2239-48. PubMed ID: 8552900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample Size Re-Estimation without Breaking the Blind in Clinical Trial.
    Wu CH
    J Biopharm Stat; 2015; 25(5):1114-29. PubMed ID: 25630031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
    Friede T; Kieser M
    Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
    Harden M; Friede T
    Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal pilot studies II: comparison of various procedures.
    Zucker DM; Wittes JT; Schabenberger O; Brittain E
    Stat Med; 1999 Dec; 18(24):3493-509. PubMed ID: 10611621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining different phases in the development of medical treatments within a single trial.
    Bauer P; Kieser M
    Stat Med; 1999 Jul; 18(14):1833-48. PubMed ID: 10407255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs.
    Herrmann C; Rauch G
    Methods Inf Med; 2021 May; 60(1-02):1-8. PubMed ID: 33648007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian adaptive blinded sample size adjustment method for risk differences.
    Hartley AM
    Pharm Stat; 2015; 14(6):488-514. PubMed ID: 26403845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
    Herrmann C; Pilz M; Kieser M; Rauch G
    Stat Med; 2020 Jul; 39(15):2067-2100. PubMed ID: 32249968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T; Mitchell C; Müller-Velten G
    Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a stopping rule based on total treatment failures: the postoperative Crohn's disease trial.
    Steinhart AH; O'Rourke K; Wolff BG; McLeod RS
    J Clin Epidemiol; 1992 May; 45(5):495-504. PubMed ID: 1588355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.